New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 23, 2014
09:40 EDTSNNSmith & Nephew temporarily ceases commercial distribution of RENASYS in the U.S.
Smith & Nephew announces that it has temporarily ceased commercial distribution of the RENASYS Negative Pressure Wound Therapy product line in the United States. This action follows instruction from the FDA to obtain new regulatory clearances through the premarket notification process in respect of certain design enhancements made to RENASYS systems. The applications for clearance have now been filed and are awaiting action.This action only affects RENASYS products in the United States. Other NPWT products, including PICO, Smith & Nephew's portable, canister-free system, are not affected. Smith & Nephew is working cooperatively with the FDA to address its concerns in order to resume distribution of RENASYS products in the United States as soon as possible and regrets any disruption caused to customers. Sales of RENASYS products in the United States accounted for less than 5% of global Advanced Wound Management revenue in 2013.
News For SNN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 24, 2014
08:46 EDTSNNStryker weighing renewed Smith & Nephew bid, Bloomberg reports
Subscribe for More Information
07:46 EDTSNNPfizer seen set to move on from AstraZeneca as restrictions lift, Telegraph says
Subscribe for More Information
November 21, 2014
09:27 EDTSNNRumors of Smith & Nephew bid from Stryker intensify, Daily Mail says
Shares of Smith & Nephew (SNN) rallied in U.K. trading amid "intensified" rumors that Stryker (SYK) will make a GBP 13B plus bid for its rival when its Takeover Panel restrictions are removed at month end, according to The Daily Mail's "This is Money." Reference Link
November 19, 2014
07:39 EDTSNNSWM to acquire assets from Smith & Nephew, terms not disclosed
Subscribe for More Information
07:11 EDTSNNSanofi drawing up list of CEO candidates to repalce Viehbacher, Reuters reports
Sanofi's (SNY) board is in the process of drawing up a short list of CEO candidates to replace Chris Viehbacher, sources tell Reuters. Jean-Rene Fourtou, a Sanofi director and the honorary chairman of media group Vivendi (VIVHY), has been selected to lead the appointments and governance committee that will select the next CEO. Smith & Nephew (SNN) CEO Olivier Bohuon, AstraZeneca (AZN) CEO Pascal Soriot and former Wyeth CEO Bernard Poussot have been rumored to be potential contenders for the CEO position. Reference Link
November 18, 2014
15:04 EDTSNNSmith & Nephew management to meet with Jefferies
Subscribe for More Information
November 10, 2014
11:58 EDTSNNSmith & Nephew hold capital markets day
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use